Melissa Melinder, whose daughter took a GLP-1 because she thought the medication eased stomachaches, said her daughter was ...

Medicines and Healthcare products Regulatory Agency experts have issued a stern warning over two particular brands ...

On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...

Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...

Last month, the Trump administration announced major plans to slash prices of GLP-1s, including Ozempic, Wegovy, Zepbound, and Mounjaro. The agreement will lower prices of these medications from ...

Turn-based roulette games aren’t new, but they continue to be popular due to the development of interesting mechanics and the tense atmosphere that arises from testing your luck. The Side Effects game ...

A new study compared the effects of 30 drugs on cholesterol, blood pressure and weight gain. By Chloe W. Shakin A new large-scale analysis found that the short-term cardiovascular and metabolic side ...

When one starts watching Adult Swim’s Common Side Effects, it’s easy to feel confused about exactly what it is. Is it a comedy? A thriller? A drama? A sci-fi epic? A bizarre drug trip? After a while, ...

In May 2025, the FDA approved numerous biosimilars as interchangeable with Stelara ® (ustekinumab) and Humira ® (adalimumab), bringing the total number of Stelara ® interchangeables to four, plus an ...

GUANGZHOU, China and LONDON, May 27, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets ...

Patients may now switch between Otulfi and Stelara without requiring a prescription change from a health care provider. The Food and Drug Administration (FDA) has designated Otulfi ® (ustekinumab-aauz ...